Exane Derivatives’s Resideo Technologies REZI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$971 Hold
50
﹤0.01% 507
2022
Q1
$1.19K Hold
50
﹤0.01% 795
2021
Q4
$1.3K Hold
50
﹤0.01% 688
2021
Q3
$1.24K Hold
50
﹤0.01% 837
2021
Q2
$1.42K Hold
50
﹤0.01% 843
2021
Q1
$1.41K Hold
50
﹤0.01% 707
2020
Q4
$1.06K Hold
50
﹤0.01% 671
2020
Q3
$550 Hold
50
﹤0.01% 667
2020
Q2
$586 Hold
50
﹤0.01% 599
2020
Q1
$242 Hold
50
﹤0.01% 648
2019
Q4
$597 Hold
50
﹤0.01% 602
2019
Q3
$717 Hold
50
﹤0.01% 559
2019
Q2
$1.1K Sell
50
-1
-2% -$21 ﹤0.01% 554
2019
Q1
$983 Sell
51
-600
-92% -$13.3K ﹤0.01% 499
2018
Q4
$13.4K Buy
+651
New +$13.9K ﹤0.01% 448

Other funds holding REZI

Exane Derivatives's REZI Position: Q2 2022 in Review

Exane Derivatives held its Resideo Technologies (REZI) position steady in Q2 2022 at 50 shares worth $971. The position accounts for ﹤0.01% of the portfolio, ranked #507.

Exane Derivatives first reported a position in REZI in Q4 2018 and has held it in 15 quarters since. The position peaked at $13.4K in Q4 2018. 366 funds tracked by Wall St. Rank hold REZI as of Q2 2022.

  • Exane Derivatives held 50 shares of Resideo Technologies worth $971 as of Q2 2022.
  • Exane Derivatives left its Resideo Technologies share count unchanged in Q2 2022.
  • Resideo Technologies made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #507 holding.
  • Exane Derivatives first reported a position in Resideo Technologies in Q4 2018 and has held it in 15 quarters since.
  • Exane Derivatives's Resideo Technologies position peaked at $13.4K in Q4 2018.
  • 366 funds tracked by Wall St. Rank held Resideo Technologies as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.